CJC-1295 No Dac 5mg Ipamorelin 5mg (10mg Total Peptide Blend)

CJC-1295 / Ipamorelin 5mg/5mg Blend – Research Peptide

Product OverviewThis combination peptide includes equal parts CJC-1295 and Ipamorelin, with 5mg of each per vial (10mg total). CJC-1295 is a modified GRF (1-29) analog, while Ipamorelin is a growth hormone–releasing peptide. Together, they are commonly used in research to study how different pathways involved in growth hormone signaling interact. The product is supplied as a lyophilized (freeze-dried) powder for laboratory use.

Mechanism of ActionIn research settings, this blend targets two separate but related pathways tied to growth hormone release. CJC-1295 works through GHRH receptor activity, while Ipamorelin acts on the ghrelin receptor (GHSR-1a). When used together in controlled studies, they allow researchers to examine how these pathways function in parallel and how they may influence growth hormone signaling when activated at the same time.

Research BackgroundPrevious studies have explored each compound individually as well as in combination. Early work by Raun et al. helped define the activity of both peptides, while later research has shown that activating both GHRH and ghrelin pathways together can produce enhanced growth hormone responses in preclinical models. These findings support continued investigation into their combined effects.

Product Details & Storage

• Form: White lyophilized powder

• Total content: 10mg (5mg CJC-1295 + 5mg Ipamorelin)

• Storage: Keep at -20°C, protected from light and moisture

• Reconstitution: Use sterile saline or bacteriostatic water

• Shelf life: Up to 24 months when stored properly

• Purity: >99% (HPLC tested)

• Format: Single vial

DisclaimerFor research use only. Not intended for human consumption, medical use, or therapeutic applications. All information is based on preclinical research. Proper regulatory approval and compliance are required before use.